NC-410

N/A

Report date: 2024/11/15 14:39:53

Base Information

Drug NameNC-410
Drug Alias NameNC-410
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionT lymphocytes stimulantsDendritic cells stimulantsLeukocyte-associated immunoglobulin-like receptor 1 antagonists
TargetsLeukocyte-associated immunoglobulin-like receptor 1
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNextcure Inc
China Registration ClassN/A

Develop Information

Active CompaniesNextcure Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic Neoplasms
Inactive IndicationsOvarian NeoplasmsStomach NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A